152128-77-3: Emtricitabine Sulfoxide (Mixture of Diastereomer)
Emtricitabine Sulfoxide Impurity (CAS No.152128-77-3) is a nucleoside reverse transcriptase inhibitor (NRTI) in combination with other antiviral agents it shows activity against HIV. It is approved for use in combination therapy.
Additional information on CAS 152128-77-3
Emtricitabine S-Oxide Impurity; Emtricitabine IP Impurity H; 4-Amino-5-fluoro-1-[(2R, 5S)-2-(hydroxymethyl)-3-oxido-1, 3-oxathiolan-5-yl]-2(1H)-pyrimidinone; [2R-(2?, 5?)]-4-Amino-5-fluoro-1-[2-(hydroxymethyl)
'Sax, Paul E., et al. “Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Dolutegravir with Emtricitabine and Tenofovir Alafenamide, for Initial Treatment of HIV-1 Infection (GS-US-380–1490): A Randomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial.” The Lancet, vol. 390, no. 10107, Nov. 2017, pp. 2073–82, https://doi.org/10.1016/s0140-6736(17)32340-1. Bang, Lynne M., and Lesley J. Scott. “Emtricitabine.” Drugs, vol. 63, no. 22, 2003, pp. 2413–24, https://do
Other products related to emtricitabine
|CAS No.||Name of Impurity||Parent Drug||Catalogue No.|